CVS
56
-2
ETN
79
7
KIM
66
8
NSC
70
17
AAP
29
9
CHRW
71
14
BXP
50
4
CSCO
64
4
AMAT
60
7
ALLE
60
-2
JBHT
39
11
CMS
57
-11
KEY
74
9
LNC
69
7
ACN
59
7
HRL
32
-6
AME
66
6
GLW
61
6
DG
23
-4
NWSA
91
-6
CVS
56
-2
ETN
79
7
KIM
66
8
NSC
70
17
AAP
29
9
CHRW
71
14
BXP
50
4
CSCO
64
4
AMAT
60
7
ALLE
60
-2
JBHT
39
11
CMS
57
-11
KEY
74
9
LNC
69
7
ACN
59
7
HRL
32
-6
AME
66
6
GLW
61
6
DG
23
-4
NWSA
91
-6
Financhill
Back

Verona Pharma PLC Stock Price Chart

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
64

VRNA
Verona Pharma PLC

Last Price:
$67.06
Seasonality Move:
16.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Verona Pharma PLC Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 69.2 Sell
20-day SMA: 65.84 Buy
50-day SMA: 64.01 Buy
200-day SMA: 44.81 Buy
8-day EMA: 67.69 Sell
20-day EMA: 66.36 Buy
50-day EMA: 63.35 Buy
200-day EMA: 47.97 Buy

Verona Pharma PLC Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.78 Buy
Relative Strength Index (14 RSI): 53.9 Buy
Chaikin Money Flow: 1128327 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.51 - 70.07) Buy
Bollinger Bands (100): (49.82 - 67.24) Buy

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Verona Pharma PLC Stock

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 67.53 while VRNA 8-day simple moving average is 69.20, which is a Sell signal.
  • The stock price of VRNA is 67.53 while Verona Pharma PLC 20-day SMA is 65.84, which makes it a Buy.
  • Verona Pharma PLC 50-day simple moving average is 64.01 while VRNA share price is 67.53, making it a Buy technically.
  • VRNA stock price is 67.53 and Verona Pharma PLC 200-day simple moving average is 44.81, creating a Buy signal.

VRNA Technical Analysis vs Fundamental Analysis

Buy
64
Verona Pharma PLC (VRNA) is a Buy

Is Verona Pharma PLC a Buy or a Sell?

  • Verona Pharma PLC stock is rated a Buy
    The current Verona Pharma PLC [VRNA] share price is $67.53. The Score for VRNA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.

Verona Pharma PLC Stock Info

Market Cap:
5.7B
Price in USD:
67.53
Share Volume:
1.4M

Verona Pharma PLC 52-Week Range

52-Week High:
74.18
52-Week Low:
11.39
Buy
64
Verona Pharma PLC (VRNA) is a Buy

Verona Pharma PLC Share Price Forecast

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 67.53 while VRNA 8-day exponential moving average is 67.69, which is a Sell signal.
  • The stock price of VRNA is 67.53 while Verona Pharma PLC 20-day EMA is 66.36, which makes it a Buy.
  • Verona Pharma PLC 50-day exponential moving average is 63.35 while VRNA share price is 67.53, making it a Buy technically.
  • VRNA stock price is 67.53 and Verona Pharma PLC 200-day simple moving average is 47.97, creating a Buy signal.

Fundamental Analysis of Verona Pharma PLC

Is Verona Pharma PLC a good investment?

  • Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.42 per share, an increase this year of $2.67 per share, and a decrease next year of $0.87 per share.

Technical Analysis of Verona Pharma PLC

Should I short Verona Pharma PLC stock?

* Verona Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.